What costs the U.S. $197.3 billion?
Slow death of rebates?
How robust is propensity score matching?
Trump and fetal tissue research.
N.Y. Times: “Balancing prices and access to drugs for the patients of today with the innovation that will benefit those of tomorrow will take ingenuity, as well as a lot of political will.”
Links posted first on http://drugsscreeningpage.blogspot.com/
No comments:
Post a Comment